Based in France, Dermascan is a startup founded in 2026. Brouky records 1 investor associated with the company.
Dermascan develops innovative medical devices for dermatology. It utilizes advanced imaging and artificial intelligence to improve the diagnosis, monitoring, and treatment of skin diseases for healthcare professionals.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.